Author details

Full Name

William J Gibson

Affiliation

ORCID

Career Start Year

2003

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37461636	Bifunctional small molecules that induce nuclear localization and targeted transcriptional regulation.	bioRxiv	2023
31535314	Machine learning versus traditional risk stratification methods in acute coronary syndrome: a pooled randomized clinical trial analysis.	J Thromb Thrombolysis	2020
32433464	Loss of heterozygosity of essential genes represents a widespread class of potential cancer vulnerabilities.	Nat Commun	2020
30442683	<i>PIK3CA</i> Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial Carcinoma.	Clin Cancer Res	2019
29976285	Fatal or Irreversible Bleeding and Ischemic Events With Rivaroxaban in Acute CoronaryÂ Syndrome.	Journal of the American College of Cardiology	2018
28177281	Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability.	Elife	2017
28713588	Genomic landscape of high-grade meningiomas.	NPJ Genom Med	2017
28664899	Corrigendum: Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth.	Sci Rep	2017
28659636	Erratum: SWELL1 is a regulator of adipocyte size, insulin signalling and glucose homeostasis.	Nature Cell Biology	2017
28561048	Erratum: SWELL1 is a regulator of adipocyte size, insulin signalling and glucose homeostasis.	Nature Cell Biology	2017
28436964	SWELL1 is a regulator of adipocyte size, insulin signalling and glucose homeostasis.	Nature Cell Biology	2017
29263836	Erratum: Genomic landscape of high-grade meningiomas.	NPJ Genom Med	2017
27707790	Landscape of Genomic Alterations in Pituitary Adenomas.	Clin Cancer Res	2017
27797976	Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid Cancer.	Clin Cancer Res	2017
27160768	Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth.	Sci Rep	2016
27348297	The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis.	Nat Genet	2016
27058668	EGLN1 Inhibition and Rerouting of Î±-Ketoglutarate Suffice for Remote Ischemic Protection.	Cell	2016
27338572	Corrigendum: Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth.	Sci Rep	2016
26919427	EGLN1 Inhibition and Rerouting of Î±-Ketoglutarate Suffice for Remote Ischemic Protection.	Cell	2016
26829751	MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism.	Nat Genet	2016
25963524	ARID1A and TERT promoter mutations in dedifferentiated meningioma.	Cancer Genet	2015
25415225	Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients.	Oncotarget	2015
24297863	BET bromodomain inhibition of MYC-amplified medulloblastoma.	Clin Cancer Res	2014
23734001	Timing of myocardial trpm7 deletion during cardiogenesis variably disrupts adult ventricular function, conduction, and repolarization.	Circulation	2013
23463345	Dysfunctional endothelial cells directly stimulate cancer inflammation and metastasis.	International Journal of Cancer	2013
22516446	Heparanase regulates thrombosis in vascular injury and stent-induced flow disturbance.	Journal of the American College of Cardiology	2012
21422389	Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings.	Circulation	2011
18766299	Transfusion associated microchimerism: a heretofore little-recognized complication following transfusion.	Journal of Thrombosis and Thrombolysis	2009
18425623	Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 years.	Journal of Thrombosis and Thrombolysis	2009
18222256	Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters.	Ann Thorac Surg	2008
18818881	Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction.	Journal of Thrombosis and Thrombolysis	2008
17000630	The association of impaired myocardial perfusion and monocytosis with late recovery of left ventricular function following primary percutaneous coronary intervention.	European Heart Journal	2006
12943884	Association of the Fibonacci Cascade with the distribution of coronary artery lesions responsible for ST-segment elevation myocardial infarction.	American Journal of Cardiology	2003